GDP compliance for medical cannabis shipments is a set of concrete documentation requirements that must be in place before, during, and after every international shipment. Importers in Germany, Australia, the UK, and other regulated markets are increasingly auditing their Thai suppliers' distribution documentation as part of supplier qualification. An exporter who cannot produce complete, coherent GDP shipment files will fail a pharmaceutical-grade buyer's supplier qualification audit regardless of how good the product is, and will lose the commercial relationship as a consequence.
Before Shipment: The Pre-Dispatch Documentation File
A GDP-compliant pre-shipment file must contain: a pre-shipment quality check record confirming product condition, packaging integrity, and temperature monitoring system installation; the product temperature specification defining the acceptable range throughout transit; calibration certificates for all temperature monitoring devices deployed in the shipment; and chain-of-custody transfer documentation signed by the responsible person at the Thai facility. INCB export authorization from the ONCB and the destination country import permit from the relevant competent authority (BfArM in Germany, ODC in Australia, Home Office in the UK, BMC in the Netherlands) must both be in the file before dispatch. No shipment should leave Thailand before all authorizations are confirmed, documented, and cross-checked for consistency of product description, quantity, and party details.
During Transit: Temperature Monitoring Requirements
EU GDP guidelines, published in the Official Journal of the European Union, require that all medicinal products be transported under conditions that meet their marketing authorization or, where no marketing authorization exists, the manufacturer's or importer's specification. For medical cannabis, this means a calibrated, certified temperature monitoring device must accompany every shipment and produce an unbroken record from origin to destination. For high-value medical cannabis air freight, a single-use data logger is the appropriate tool: it provides a tamper-evident environmental record with no ambiguity about which shipment the data corresponds to, and no reverse logistics burden at the destination. The logger must be placed correctly inside the shipment packaging — not on the external surface where it would record ambient conditions rather than the conditions around the product.
DeeMED uses the Frigga V5 Core single-use data logger for medical cannabis export shipments. It records continuous temperature and humidity data throughout transit and produces a PDF report downloadable at delivery without proprietary software, which can be immediately shared with the importer's quality team as part of the GDP shipment record.
Post-Delivery: Record Retention and Excursion Management
Upon delivery, the receiver downloads and reviews the data logger report. This report forms part of the GDP shipment record and must be retained by both the shipper and the receiver. EU GDP guidelines specify that records must be retained for the product's shelf life plus one year. Any temperature excursion recorded during transit must be formally investigated and documented, concluding with a written disposition decision: accept with scientific justification, reject, or quarantine pending stability data review. An undocumented excursion or an excursion with no disposition record is a GDP non-conformance that will be identified in any supplier audit.
Why This Matters Commercially
International pharmaceutical buyers who conduct supplier audits review GDP shipment files as a primary indicator of supplier quality maturity. An exporter who can immediately produce a complete, coherent GDP file for any shipment in the past two years signals to a buyer that quality is embedded in their operations rather than being performed for audits. An exporter who cannot produce these records, or who produces incomplete records, signals the opposite. DeeMED manages end-to-end GDP documentation for medical cannabis export shipments, including Frigga data logger deployment, INCB documentation coordination, ONCB export authorization, and post-delivery record management and retention.
Sources & Further Reading
- European Commission, EU Guidelines on Good Distribution Practice for Medicinal Products for Human Use (2013/C 343/01)
- AustCham Thailand, "A Guide to Exporting Medical Cannabis from Thailand to Australia"
- INCB, UN Single Convention on Narcotic Drugs (1961) — international legal framework for cannabis export